4.4 Article

N-Terminal clustering of the O-glycosylation sites in the Mycobacterium tuberculosis lipoprotein SodC

期刊

GLYCOBIOLOGY
卷 19, 期 1, 页码 38-51

出版社

OXFORD UNIV PRESS INC
DOI: 10.1093/glycob/cwn102

关键词

-

资金

  1. National Institutes of Health
  2. NIAID [RO1 AI-056257, NO1 AI-75320, HHSN26620040091c]
  3. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI075320, R01AI056257] Funding Source: NIH RePORTER

向作者/读者索取更多资源

SodC is one of two superoxide dismutases produced by Mycobacterium tuberculosis. This protein was previously shown to contribute to virulence and to act as a B-cell antigen. SodC is also a putative lipoprotein, and like other Sec-translocated mycobacterial proteins it was suggested to be modified with glycosyl units. To definitively define the glycosylation of SodC, we applied an approach that combined site-directed mutagenesis, lectin binding, and mass spectrometry. This resulted in identification of six O-glycosylated residues within a 13-amino-acid region near the N-terminus. Each residue was modified with one to three hexose units, and the most dominant SodC glycoform was modified with nine hexose units. In addition to O-glycosylation of threonine residues, this study provides the first evidence of serine O-glycosylation in mycobacteria. When combined with bioinformatic analyses, the clustering of O-glycosylation appeared to occur in a region of SodC with a disordered structure and not in regions important to the enzymatic activity of SodC. The use of recombinant amino acid substitutions to alter glycosylation sites provided further evidence that glycosylation influences proteolytic processing and ultimately positioning of cell wall proteins.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Chemistry, Medicinal

Elucidation of a Human Urine Metabolite as a Seryl-Leucine Glycopeptide and as a Biomarker of Effective Anti-Tuberculosis Therapy

Bryna L. Fitzgerald, M. Nurul Islam, Barbara Graham, Sebabrata Mahapatra, Kristofor Webb, W. Henry Boom, Stephanus T. Malherbe, Moses L. Joloba, John L. Johnson, Jill Winter, Gerhard Walzl, John T. Belisle

ACS INFECTIOUS DISEASES (2019)

Article Infectious Diseases

A pilot metabolomics study of tuberculosis immune reconstitution inflammatory syndrome

Carlos A. M. Silva, Barbara Graham, Kristofor Webb, Laura Vari Ashton, Marisa Harton, Annie F. Luetkemeyer, Samantha Bokatzian, Reem Almubarak, Sebabrata Mahapatra, Laura Hovind, Michelle A. Kendall, Diane Havlir, John T. Belisle, Mary Ann De Groote

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2019)

Article Biotechnology & Applied Microbiology

Increased serum sialic acid is associated with morbidity and mortality in a murine model of dengue disease

Diego A. Espinosa, P. Robert Beatty, Henry Puerta-Guardo, M. Nurul Islam, John T. Belisle, Rushika Perera, Eva Harris

JOURNAL OF GENERAL VIROLOGY (2019)

Article Immunology

Distinct serum biosignatures are associated with different tuberculosis treatment outcomes

Katharina Ronacher, Novel N. Chegou, Lanie Kleynhans, Joel F. Djoba Siawaya, Nelita du Plessis, Andre G. Loxton, Elizna Maasdorp, Gerard Tromp, Martin Kidd, Kim Stanley, Magdalena Kriel, Angela Menezes, Andrea Gutschmidt, Gian D. van der Spuy, Robin M. Warren, Reynaldo Dietze, Alphonse Okwera, Bonnie Thiel, John T. Belisle, Jacqueline M. Cliff, W. Henry Boom, John L. Johnson, Paul D. van Helden, Hazel M. Dockrell, Gerhard Walzl

TUBERCULOSIS (2019)

Article Multidisciplinary Sciences

Immunoproteomic analysis of Borrelia miyamotoi for the identification of serodiagnostic antigens

Emma K. Harris, Marisa R. Harton, Maria Angela de Mello Marques, John T. Belisle, Claudia R. Molins, Nicole Breuner, Gary P. Wormser, Robert D. Gilmore

SCIENTIFIC REPORTS (2019)

Article Biochemical Research Methods

Host Metabolic Response in Early Lyme Disease

Bryna L. Fitzgerald, Claudia R. Molins, M. Nurul Islam, Barbara Graham, Petronella R. Hove, Gary P. Wormser, Linden Hu, Laura Ashton, John T. Belisle

JOURNAL OF PROTEOME RESEARCH (2020)

Article Immunology

Metabolic Response in Patients With Post-treatment Lyme Disease Symptoms/Syndrome

Bryna L. Fitzgerald, Barbara Graham, Mark J. Delorey, Adoracion Pegalajar-Jurado, M. Nurul Islam, Gary P. Wormser, John N. Aucott, Alison W. Rebman, Mark J. Soloski, John T. Belisle, Claudia R. Molins

Summary: This study used metabolomics to analyze metabolic responses in patients with Post-treatment Lyme disease symptoms/syndrome (PTLDS) compared to clinically cured non-PTLDS patients. The findings revealed observable metabolic differences between PTLDS and non-PTLDS patients at multiple time points, with distinct patterns of metabolite abundance. A small number of metabolites could be used to define PTLDS versus non-PTLDS patients at specific time points, and these findings were validated in a second patient cohort. These results suggest that metabolite-based measurement can help distinguish patients with PTLDS and provide insights into the underlying biochemistry of PTLDS.

CLINICAL INFECTIOUS DISEASES (2021)

Article Biology

Dengue virus dominates lipid metabolism modulations in Wolbachia-coinfected Aedes aegypti

Cassandra Koh, M. Nurul Islam, Yixin H. Ye, Nunya Chotiwan, Barbara Graham, John T. Belisle, Konstantinos A. Kouremenos, Saravanan Dayalan, Dedreia L. Tull, Stephan Klatt, Rushika Perera, Elizabeth A. McGraw

COMMUNICATIONS BIOLOGY (2020)

Article Microbiology

An Infection-Tolerant Mammalian Reservoir for Several Zoonotic Agents Broadly Counters the Inflammatory Effects of Endotoxin

Gabriela Balderrama-Gutierrez, Ana Milovic, Vanessa J. Cook, M. Nurul Islam, Youwen Zhang, Hippokratis Kiaris, John T. Belisle, Ali Mortazavi, Alan G. Barbour

Summary: The study revealed significant differences in responses to infection between white-footed deermice and mice, suggesting that deermice possess adaptive traits to moderate inflammation and better balance infection resistance and tolerance. These findings have implications for studying infection tolerance in other important reservoir species.
Article Immunology

An rfuABCD-Like Operon and Its Relationship to Riboflavin Utilization and Mammalian Infectivity by Borrelia burgdorferi

Matthew K. Muramatsu, Jianli Zhou, Bryna L. Fitzgerald, Ranjit K. Deka, John T. Belisle, Michael Norgard

Summary: This research highlights the importance of riboflavin and Flavin pools for the growth of Borrelia burgdorferi and suggests that flavin utilization and its downstream products may play a more significant role in the pathogenesis of this spirochete than previously thought. Mutation in specific genes related to riboflavin import and synthesis can lead to resistance to certain antimicrobial agents and attenuation of disease in a murine model.

INFECTION AND IMMUNITY (2021)

Article Multidisciplinary Sciences

Identification and functional analysis of a galactosyltransferase capable of cholesterol glycolipid formation in the Lyme disease spirochete Borrelia burgdorferi

Petronella R. Hove, Forgivemore Magunda, Maria Angela de Mello Marques, M. Nurul Islam, Marisa R. Harton, Mary Jackson, John T. Belisle

Summary: This study identified the key enzyme BB0572 responsible for cholesterol glycolipid formation in Bb, demonstrating its function as a galactosyltransferase. Mutation in BB0572's predicted active site hindered its ability to catalyze the formation of cholesterol glycolipids.

PLOS ONE (2021)

Article Immunology

Reductive Power Generated by Mycobacterium leprae Through Cholesterol Oxidation Contributes to Lipid and ATP Synthesis

Thabatta L. S. A. Rosa, Maria Angela M. Marques, Zachary DeBoard, Kelly Hutchins, Carlos Adriano A. Silva, Christine R. Montague, Tianao Yuan, Julio J. Amaral, Georgia C. Atella, Patricia S. Rosa, Katherine A. Mattos, Brian C. VanderVen, Ramanuj Lahiri, Nicole S. Sampson, Patrick J. Brennan, John T. Belisle, Maria Cristina Pessolani, Marcia Berredo-Pinho

Summary: Upon infection, Mycobacterium leprae induces accumulation of cholesterol in Schwann cells, which is potentially delivered to the intracellular bacterium. Cholesterol oxidation is an essential catabolic pathway for M. leprae pathogenicity, with 3 beta-HSD as a potential drug target for leprosy treatment.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)

Article Multidisciplinary Sciences

Biomarker selection and a prospective metabolite-based machine learning diagnostic for lyme disease

Eric R. Kehoe, Bryna L. Fitzgerald, Barbara Graham, M. Nurul Islam, Kartikay Sharma, Gary P. Wormser, John T. Belisle, Michael J. Kirby

Summary: The study developed a pipeline for data preprocessing, biomarker selection, and classification of LCMS serum samples for Lyme disease diagnosis, achieving a 98.13% test balanced success rate. The methodology is generalizable and can be adapted to other LCMS or metabolomics data sets.

SCIENTIFIC REPORTS (2022)

Correction Immunology

Reductive Power Generated by Mycobacterium leprae Through Cholesterol Oxidation Contributes to Lipid and ATP Synthesis (vol 11, 709972, 2021)

Thabatta L. S. A. Rosa, Maria Angela M. Marques, Zachary DeBoard, Kelly Hutchins, Carlos Adriano A. Silva, Christine R. Montague, Tianao Yuan, Julio J. Amaral, Georgia C. Atella, Patricia S. Rosa, Katherine A. Mattos, Brian C. VanderVen, Ramanuj Lahiri, Nicole S. Sampson, Patrick J. Brennan, John T. Belisle, Maria Cristina V. Pessolani, Marcia Berredo-Pinho

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)

Article Microbiology

Localization of EccA3 at the growing pole in Mycobacterium smegmatis

Nastassja L. Kriel, Mae Newton-Foot, Owen T. Bennion, Bree B. Aldridge, Carolina Mehaffy, John T. Belisle, Gerhard Walzl, Robin M. Warren, Samantha L. Sampson, Nico C. Gey van Pittius

Summary: In this study, the sub-cellular location of EccA(3) in mycobacteria was investigated. Time-lapse microscopy showed that EccA(3) localizes to the growing pole in M. smegmatis. The co-purification of EccA(3) with proteins involved in polar growth, mycolic acid synthesis, and secretion systems suggests that EccA(3) is located at the site of active cell growth.

BMC MICROBIOLOGY (2022)

暂无数据